Topic:

Emerging Markets

Latest Headlines

Latest Headlines

Japan's Eisai amps up in China with new manufacturing plant

The Japanese drugmaker will use the plant to tap growing demand in that country, as well as an export base for other emerging markets in Asia.

CardioDx reaches to India with Core partnership

CardioDx, a 2012 Fierce 15 winner, has partnered with India's Core Diagnostics to distribute its coronary artery disease test in the country's burgeoning market.

Eisai building plant in China to manufacture parenteral products

Drugmakers from around the world are hustling to expand in China's fast-growing drug market. Merck just opened a $120 million packaging plant there and now Japan's Eisai is set to build a new plant to make parenteral products in Suzhou, Jiangsu.

Thailand government vaccine plant at center of probe

Four years ago, a federal agency in Thailand began building a plant intended to produce enough flu vaccine to protect the country in case of a pandemic. But anticorruption investigators for the current government now want answers as to why the plant is two years overdue. 

Panacea Biotec accused of selling expired vaccines

India's government wants the country to become the world's preeminent low-cost vaccine supplier, but it will first have to overcome problems of its own making.

South Africa follows India's lead with proposed drug-patent reforms

South Africa plans to revamp its intellectual-property laws to make it more difficult for pharma companies to win protection for new versions of older drugs. The move comes soon after India's top court backed strict requirements for drug patents.

Report: Electrophysiology device sales grow fastest in Asia

Electrophysiology devices (think ablation catheters and medical lasers) should reach $4.4 billion in global sales by 2015 as the sector approaches nearly double-digit growth, concludes a new industry report.

Ishrak: Medtronic has a keen eye on India

Medtronic CEO Omar Ishrak has made no secret of how important emerging markets are to his company's growth, and India's swelling population and expanding medical access are key to the device giant's future, he said.

Indian clinical trials plunge amid increased scrutiny

India's government is struggling to crack down on loosely regulated clinical trials that have killed hundreds of patients around the country, and while it's unclear if its efforts have made the process safer, they've certainly slowed things down.

Will Brazil grab the emerging-markets popularity crown?

China and India may top the list of fastest-growing pharma markets, but Brazil is no slouch, either. Drugmakers are wheeling and dealing there at an increasingly faster pace, as companies like Merck and Reckitt Benckiser join old-timers like Sanofi and GlaxoSmithKline in beefing up there.